C17H25N3O3S
Neat
351.47
334981-13-4; 2H-Indol-2-one, 3-[2-(dimethylamino)ethyl]-1, 3-dihydro-5-[(1-pyrrolidinylsulfonyl)methyl]-; 3-[2-(Dimethylamino)ethyl]-1, 3-dihydro-5-[(1-pyrrolidinylsulfonyl)methyl]-2H-indol-2-one; 3-[2-(dimethylamino)ethyl]-5-(pyrrolidin-1-ylsulfonylmethyl)-1, 3-dihydroindol-2-one; VAK3HT684K; DTXSID901124052; 2-HYDROXYALMOTRIPTAN [USP IMPURITY]; 1H-Indol-2-ol and 3-[2-(dimethylamino)ethyl]-5-[(1-pyrrolidinylsulfonyl)methyl]-; 3-(2-(dimethylamino)ethyl)-5-((pyrrolidin-1-ylsulfonyl)methyl)indolin-2-one; 3-[2-(Dimethylamino)ethyl]-5-[(1-pyrrolidinylsulfonyl)methyl]-1H-indol-2-ol
3-[2-(dimethylamino)ethyl]-5-(pyrrolidin-1-ylsulfonylmethyl)-1 and 3-dihydroindol-2-one
InChI=1S/C17H25N3O3S/c1-19(2)10-7-14-15-11-13(5-6-16(15)18-17(14)21)12-24(22,23)20-8-3-4-9-20/h5-6,11,14H,3-4,7-10,12H2,1-2H3,(H,18,21)